Panniculitis in rheumatology: Unresolved issues
https://doi.org/10.14412/1996-7012-2016-3-5-10
Abstract
Panniculitis (PN) is a group of heterogeneous inflammatory diseases characterized by involvement of the subcutaneous fat and frequently locomotor system and viscera. An analysis of the literature suggests that so far there are no studies using a uniform large cohort of patients with different types of PN and further carefully tracking their outcomes over several years. Some authors still question the nosological independence of Weber–Christian PN. The issues of treatment in general and its specific forms remain open. The lack of conventional treatments, regardless of the form of PN, necessitates in vivo clinical trials of various regimens, by compar-ing the course and outcomes of the disease. Recognizing the possible predictors of a relapse in various forms of PN and assessing the long-term results of treatment are of supreme importance since, along with an analysis of the efficiency of different therapy regimens, valuable informa-tion on diverse factors that significantly influence the prognosis of the disease can be obtained.
About the Authors
N. M. Savushkina
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522
Russian Federation
Russian Federation
O. N. Egorova
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522
Russian Federation
Russian Federation
B. S. Belov
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522
Russian Federation
Russian Federation
References
1. Иванов ОЛ. Кожные и венерические болезни. Москва: Шико; 2006. С. 170-4. [Ivanov OL. Kozhnye i venericheskie bolezni [Skin and venereal disease]. Moscow: Shiko; 2006. P. 170-4].
2. Фитцпатрик ТБ, Бернард ДР. Кожные повреждения, имеющие общемедицинское значение. В кн.: Браунвальд Е, редактор. Внутренние болезни. Книга 2. Москва: Медицина; 1999. С. 67–82. [Fittspatrik TB, Bernard DR. Skin lesions that have medical value. In: Braunval'd E, editor. Vnutrennie bolezni. [Internal diseases]. Book 2. Moscow: Medicine; 1999. P. 67-82.].
3. Diaz Cascajo C, Borghi S, Weyers W. Panniculitis: definition of terms and diagnostic strategy. Am J Dermatopathol. 2000 Dec; 22(6):530-49.
4. Беренбейн БА, Студницина АА. Дифференциальная диагностика кожных болезней. Москва: Медицина; 1989. С. 432-59. [Berenbeyn BA, Studnitsina AA. Differentsial'naya diagnostika kozhnykh bolezney [Differential diagnosis of skin diseases]. Moscow: Medicine; 1989. P. 432-59.].
5. Вербенко ЕВ. Спонтанный панникулит. В кн.: Скрипкин ЮК, редактор. Кожные и венерические болезни. Руководство для врачей. Москва: Медицина; 1995. P. 399-410. [Verbenko EV. Idiopathic panniculitis. In: Skripkin YuK, editor. Kozhnye i venericheskie bolezni. Rukovodstvo dlya vrachei [Skin and venereal disease. A guide for physicians]. Moscow: Medicine; 1995. P. 399-410].
6. Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol. 2001 August; 45(2):163-83. doi: 10.1067/mjd.2001.114736.
7. Ryan TJ, Curri SB. Cutaneous Adipose Tissue. Dermatology Clinics. Philadelphia: JB Lippincott; 1989. Vol. 7. P. 107-19.
8. Iwasaki T, Hamano T, Ogata A, et al. Successful treatment of a patient with febrile, lobular panniculitis (Weber-Christian disease) with oral cyclosporin A: implications for pathogenesis and therapy. Intern Med. 1999; 38 (7):612-4. doi: 10.2169/internalmedicine. 38.612.
9. Lamprecht P, Moosig F, Adam-Klages S, et al. Small vessel vasculitis and relapsing panniculitis periodic syndrome (TRAPS) in tumour necrosis factor receptor associated. Ann Rheum Dis. 2004 Nov; 63(11):1518-20. doi: 10.1136/ard.2003.016733.
10. Егорова ОН, Белов БС, Савушкина НМ. Панникулит: иммунологические аспекты. В кн.: VII Национальный конгресс терапевтов: Сб. тез. Москва; 2012. С. 75-6. [Egorova ON, Belov BS, Savushkina NM. Panniculitis: immunological aspects. In: VII Natsional’nyi kongress terapevtov: Sb. tez. [VII national Congress of the therapists: theses]. Moscow; 2012. P. 75- 6.].
11. Fischer-Posovszky P, Hebestreit H, Hofmann AK, et al. Role of CD95-mediated adipocyte loss in autoimmune lipodystrophy. J Clin Endocrinol Metab. 2006 Mar; 91(3):1129-35.
12. Requena L, Yus ES. Panniculitis Part II: mostly lobular panniculitis. J Am Acad Dermatol September 2001; 45(3): 325-64. doi: 10.1067/mjd.2001.114735.
13. Ter Poorten MC, Thiers BH. Panniculitis. Dermatol Clin. 2002 Jul; 20(3):421-33.
14. Callen JP. Panniculits. In: Isenberg DA, Maddison PJ, Woo P, et al, editors. Oxford Text Book of Rheumatology. Oxford: Oxford University Press; 2004. P. 1031-5.
15. Mert A, Ozaras R, Tabak F, et al. Erythema nodosum: an experience of 10 years. Scand J Infect Dis. 2004; 36:424-7. doi: 10.1080/00365540410027184.
16. Pink A, Barker J. Erythema nodosum. Br J Hosp Med (Lond). 2012 Apr;73(4):C50-2.
17. Kisacik B, Onat AM, Pehlivan Y. Multiclinical experiences in erythema nodosum: rheumatology clinics versus dermatology and infection diseases clinics. Rheumatol Int. 2013; 33(2):315-8. doi: 10.1007/s00296-012-2413-5.
18. Puavilai S, Sakuntabhai A, Sriprachaya-Anunt S, et al. Etiology of erythema nodosum. J Med Assoc Thai. 1995;78(2):72-5.
19. Hassink RI, Pasquinelli-Egli CE, Jacomella V, et al. Conditions currently associated with erythema nodosum in Swiss children. Eur J Pediatr. 1997 Nov;156(11):851-3.
20. Моисеев СВ, Корнев БМ. Узловатая эритема: ревматизм или саркоидоз? Новый медицинский журнал. 1996;(1-2):8-10. [Moiseev SV, Kornev BM. Erythema nodosum: rheumatic disease or sarcoidosis? Novyi meditsinskii zhurnal. 1996;(1-2):8-10. (In Russ.)].
21. Вермель АЕ. Узловатая эритема в клинике внутренних болезней. Клиническая медицина; 2004;(4):4-9. [Vermel' AE. Erythema nodosum in the clinic of internal diseases. Klinicheskaya meditsina. 2004;(4): 4-9. (In Russ.)].
22. Labunski S, Posern G, Ludwig S, et al. Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol. 2001 Jan-Feb;81(1):18-21. doi: 10.1080/00015550116912.
23. Maver A, Medica I, Salobir B, et al. Polymorphisms in genes coding for mediators in the interleukin cascade and their effect on susceptibility to sarcoidosis in the Slovenian population. Int J Mol Med. 2007 Sep;20(3): 385-90. doi: 10.3892/ijmm.20.3.385.
24. Mana J, Gomez-Vaquero C, Montero A, et al. Lofgren's syndrome revisited: a study of 186 patients. Am J Med. 1999;107(3):240-5.
25. Шмидт ЕИ, Адамович ВН. Узловатая эритема у больных саркоидозом. В кн.: Республиканский сборник научных трудов: Проблемы диагностики и лечения ревматических заболеваний. Москва; 1998. С. 75-9. [Shmidt EI, Adamovich VN. Erythema nodosum in patients with sarcoidosis. In: Respublikanskiy sbornik nauchnykh trudov: Problemy diagnostiki i lecheniya revmaticheskikh zabolevaniy.[The Republican collection of scientific articles: Problems of diagnosis and treatment of rheumatic diseases]. Moscow; 1998. P. 75-9.].
26. Шапошников ОК. Хроническая узловатая эритема. Ленинград: Медицина; 1971. С. 101 [Shaposhnikov OK. Khronicheskaya uzlovataya eritema [Chronic erythema nodosum]. Leningrad: Medicine; 1971. P. 101.].
27. Papagrigoraki A, Gisondi P, Rosina P, et al. Erythema nodosum; etiological factors and relapses in a retrospective cohort study. Eur J Dermatol. 2010; 20(6):773-7. doi: 10.1684/ejd.2010.1116.
28. Salvatore M, Lynch P. Erythema nodosum, estrogens, and pregnancy. Arch Dermatol. 1980 May;116(5):557-8.
29. Yang S, Han K, Cho K, et al. Development of erythema nodosum in the course of estrogen remplacement therapy. Br J Dermatol. 1997 Aug;137(2):319-20.
30. Jeon HC, Choi M, Paik SH, et al. A case of assisted reproductive therapy induced erythema nodosum. Ann Dermatol. 2011;23(3):362-4. doi: 10.5021/ad.2011.23.3.362.
31. Михневич ЭА. Узловатая эритема и беременность. Лечебное дело. 2012;(5):64-9. [Mikhnevich EA. Erythema nodosum and pregnancy. Lechebnoe delo. 2012;(5):64-9. (In Russ.)].
32. Garcia-Porrua C, Gonzalez-Gay MA, Vazquez-Caruncho M, et al. Erythema nodosum: etiologic and predictive factors in a deёned population. Arthritis Rheum. 2000; 43(3):584- 92. doi: 10.1002/1529-0131(200003) 43:3<584::AID-ANR15>3.0.CO;2-6.
33. Sanguansermsri D, Pongcharoen S. Pregnancy immunology: decidual immune cells. Asian Pac J Allergy Immunol. 2008 Jun- Sep;26(2-3):171-81.
34. Silver RM. Immune activation early in pregnancy: trouble down the road? Am J Obstet Gynecol. 2008 Oct; 199(4):327-8. doi: 10.1016/j.ajog.2008.06.053.
35. Bartelsmeyer JA, Petrie RH. Erythema nodosum, estrogens, and pregnancy. Clin Obstet Gynecol. 1990;33(4):777-81.
36. Савельев ВС. Флебология. Москва: Медицина; 2001. 648 c. [Savel'ev VS. Flebologiya [Phlebology]. Moscow: Meditsina; 2001. 648 p.].
37. Jorizzo J, White WL, Zanolli MD, et al. Sclerosing panniculitis: a clinicopathologic assessment. Arch Dermatol. 1991 Apr;127(4):554-8. doi: 10.1001/archderm. 1991.04510010122016.
38. Tejera Segura B, Holgado S, Mateo L, et al. Lö fgren syndrome: A study of 80 cases. Medicina Clinica. 2014;143(4):166-9. doi: 10.1016/j.medcli.2014.02.029.
39. Визель ИЮ, Шмелев ЕИ, Баранова ОП и др. Мультицентровой ретроспективный анализ состояния больных саркоидозом с 10-летним интервалом наблюдения. Клиническая медицина. 2014;92(6):28-34. [Vizel' IYu, Shmelev EI, Baranova OP, et al. Multicentral retrospective analysis of patients with sarcoidosis with a 10-year observation interval. Klinicheskaya meditsina. 2014;92(6):28-34. (In Russ.)].
40. Bohn S, Bü chner S, Itin P. Erythema nodosum: 112 cases. Epidemiology, clinical aspects and histopathology. Schweiz Med Wochenschr. 1997 Jul; 127(27-28):1168-76.
41. Ubogy Z, Persellin RH. Suppression of erythema nodosum by indomethacin. Acta Dermato-Venereol. 1982;62(3):265-6.
42. Goodman LS, Brunton LL, Chabner B, et al. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill Medical; 2011.
43. Boyd AS. Etanercept treatment of erythema nodosum. Skinmed. 2007;6(4):197-9.
44. McGready R, Thwai KL, Cho T, et al. The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy. Trans R Soc Trop Med Hyg. 2002;96(2):180-4.
45. Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis. Dermatol Ther. 2010 Jul- Aug;23(4):375-88. doi: 10.1111/j.1529-8019.2010.01338.x.
46. Bruynzeel I, Stoof TJ, Willemze R. Pentoxifylline and skin inflammation. Clin Exp ermatol. 1998;23(4):168-72. doi: 10.1046/j.1365-2230.1998.00316.x.
47. Kalia S, Dutz, JP. New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther. 2007;20(4):160-74. doi: 10.1111/j.1529-8019.2007.00131.x.
48. Choonhakarn C, Chaowattanapanit S. Lipodermatosclerosis: improvement noted with hydroxychloroquine and pentoxifylline. J Am Acad Dermatol. 2012 Jun; 66(6):1013-4. doi: 10.1016/j.jaad.2011.11.942.
49. Kirch W, Duhrsen U, Hoensch H, et al. Cyclophosphamideinduced remission in Weber- Christian panniculitis. Rheumatol Int. 1985;5(5):239-40.
50. Martin RJ, Michals EL, Voth MR. Cyclophosphamide-induced remission in Weber- Christian disease: case report. Mil Med. 1977;142(2):158-60.
51. Szyszymar B, Gwiezdzinski Z. Treatment of recurrent panniculits febrilis nonsuppurativa with methotrexate. Przegl Dermatol. 1974;61(5):623-7.
52. Hotta T, Wakamatsu Y, Matsumura N, et al. Azathioprine induced remission in Weber- Christian disease. South Med J. 1981 Feb; 74(2):234-7.
53. Lamprecht P, Moosig F, Adam-Klages S, et al. Small vessel vasculitis and relapsing panniculitis periodic syndrome (TRAPS) in tumour necrosis factor receptor associated. Ann Rheum Dis. 2004;63(11):1518-20. doi: 10.1136/ard.2003.016733.
54. Al-Niaimi F, Clark C, Thorrat A, Burden AD. Idiopathic lobular panniculitis: remission induced and maintained with infliximab. Br J Dermatol. 2009 Sep;161(3): 691-2. doi: 10.1111/j.1365-2133.2009.09295.x.
55. White JW, Winkelmann RK. Weber-Christian panniculitis: a review of 30 cases with this diagnosis. J Am Acad Dermatol. 1998 July; 39(1):56-62.
Review
For citations:
Savushkina NM, Egorova ON, Belov BS. Panniculitis in rheumatology: Unresolved issues. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2016;10(3):5-10. (In Russ.) https://doi.org/10.14412/1996-7012-2016-3-5-10
Views:
785
Email this article 